| Caregiver | Test value | P value | Sig | ||
---|---|---|---|---|---|---|
Yes | No | |||||
Age | Mean ± SD | 73.73 ± 8.62 | 68.74 ± 6.99 | 3.870 | 0.000 | HS |
Range | 60–96 | 60–87 | ||||
Sex | Male | 49 (36.3%) | 18 (31.6%) | 0.393 | 0.531 | NS |
Female | 86 (63.7%) | 39 (68.4%) | ||||
LOS | Median (IQR) | 12 (7–18) | 11 (7–18) |  − 1.193 | 0.233 | NS |
Range | 2–68 | 4–34 | ||||
Education level | Low | 108 (80.0%) | 50 (87.7%) | 2.114 | 0.348 | NS |
Moderate | 16 (11.9%) | 3 (5.3%) | ||||
High | 11 (8.1%) | 4 (7.0%) | ||||
Marital status | Single | 2 (1.5%) | 1 (1.8%) | 2.361 | 0.501 | NS |
Married | 59 (43.7%) | 30 (52.6%) | ||||
Widow | 71 (52.6%) | 26 (45.6%) | ||||
Divorced | 3 (2.2%) | 0 (0.0%) | ||||
Child no | Median (IQR) | 4 (2–5) | 3.5 (2–4) |  − 0.332 | 0.740 | NS |
Range | 0–10 | 0–10 | ||||
Smoking | Yes | 13 (9.6%) | 5 (8.8%) | 0.267 | 0.875 | NS |
No | 100 (74.1%) | 41 (71.9%) | ||||
Ex-smoker | 22 (16.3%) | 11 (19.3%) | ||||
COPD | Yes | 25 (18.5%) | 6 (10.5%) | 1.891 | 0.169 | NS |
No | 110 (81.5%) | 51 (89.5%) | ||||
BA | Yes | 10 (7.4%) | 6 (10.5%) | 0.510 | 0.475 | NS |
No | 125 (92.6%) | 51 (89.5%) | ||||
Infections | Yes | 69 (51.1%) | 20 (35.1%) | 4.138 | 0.042 | S |
No | 66 (48.9%) | 37 (64.9%) | ||||
DM | Yes | 64 (47.4%) | 30 (52.6%) | 0.438 | 0.508 | NS |
No | 71 (52.6%) | 27 (47.4%) | ||||
Neurological | Yes | 46 (34.1%) | 9 (15.8%) | 6.555 | 0.010 | S |
No | 89 (65.9%) | 48 (84.2%) | ||||
Dementia | Yes | 59 (43.7%) | 0 (0.0%) | 35.962 | 0.000 | HS |
No | 76 (56.3%) | 57 (100.0%) | ||||
HF | Yes | 25 (18.5%) | 13 (22.8%) | 0.464 | 0.496 | NS |
No | 110 (81.5%) | 44 (77.2%) | ||||
CLD | Yes | 19 (14.1%) | 13 (22.8%) | 2.201 | 0.138 | NS |
No | 116 (85.9%) | 44 (77.2%) | ||||
Thyroid dis | Yes | 7 (5.2%) | 5 (8.8%) | 0.880 | 0.348 | NS |
No | 128 (94.8%) | 52 (91.2%) | ||||
HTN | Yes | 88 (65.2%) | 33 (57.9%) | 0.914 | 0.339 | NS |
No | 47 (34.8%) | 24 (42.1%) | ||||
ISHD | Yes | 41 (30.4%) | 19 (33.3%) | 0.164 | 0.686 | NS |
No | 94 (69.6%) | 38 (66.7%) | ||||
CKD | Yes | 16 (11.9%) | 11 (19.3%) | 1.839 | 0.175 | NS |
No | 119 (88.1%) | 46 (80.7%) | ||||
Cancer | Yes | 8 (5.9%) | 6 (10.5%) | 1.255 | 0.263 | NS |
No | 127 (94.1%) | 51 (89.5%) | ||||
DVT | Yes | 7 (5.2%) | 1 (1.8%) | 1.181 | 0.277 | NS |
No | 128 (94.8%) | 56 (98.2%) | ||||
UI | Yes | 88 (65.2%) | 9 (15.8%) | 39.119 | 0.000 | HS |
No | 47 (34.8%) | 48 (84.2%) | ||||
OA | Yes | 57 (42.2%) | 31 (54.4%) | 2.389 | 0.122 | NS |
No | 78 (57.8%) | 26 (45.6%) | ||||
Delirium | Yes | 24 (17.8%) | 2 (3.5%) | 6.970 | 0.008 | HS |
No | 111 (82.2%) | 55 (96.5%) | ||||
MNA | Malnurished | 56 (41.5%) | 9 (15.8%) | 13.290 | 0.001 | HS |
Risk | 54 (40.0%) | 28 (49.1%) | ||||
Normal | 25 (18.5%) | 20 (35.1%) | ||||
Depression | Yes | 33 (24.4%) | 17 (29.8%) | 0.602 | 0.438 | NS |
No | 102 (75.6%) | 40 (70.2%) | ||||
Charlson | Median (IQR) | 6 (5–7) | 5 (3–6) |  − 3.599 | 0.000 | HS |
Range | 2–12 | 2–8 | ||||
ADL | Median (IQR) | 1 (0–2) | 6 (6–6) |  − 10.495 | 0.000 | HS |
Range | 0–6 | 4–6 | ||||
IADL | Median (IQR) | 0 (0–2) | 8 (6–8) |  − 10.611 | 0.000 | HS |
Range | 0–6 | 0–8 | ||||
Medications no | Median (IQR) | 3 (2–5) | 2 (1–4.5) |  − 1.479 | 0.139 | NS |
Range | 0–10 | 0–9 | ||||
Hearing imp | Yes | 25 (18.5%) | 11 (19.3%) | 0.016 | 0.899 | NS |
No | 110 (81.5%) | 46 (80.7%) | ||||
Visual imp | Yes | 53 (39.3%) | 21 (36.8%) | 0.099 | 0.753 | NS |
No | 82 (60.7%) | 36 (63.2%) | ||||
Sleep prob | Yes | 58 (53.7%) | 5 (29.4%) | 3.467 | 0.063 | NS |
No | 50 (46.3%) | 12 (70.6%) | ||||
Sleep no | Median (IQR) | 6 (4–7) | 7 (6–8) |  − 3.682 | 0.000 | HS |
Range | 2–11 | 4–12 | ||||
Mortality | Yes | 27 (20.0%) | 8 (14.0%) | 0.957 | 0.328 | NS |
No | 108 (80.0%) | 49 (86.0%) | ||||
Comorbid | Median (IQR) | 6 (4–7) | 4 (3–5) | 5.408 |  < 0.001 | HS |
 | Range | 1–10 | 1–8 |  |  |  |